IL36RN encoded an interleukin-36-receptor antagonist [44] in renal cell carcinoma cells, and its overexpression inhibited proliferation, migration, invasion, and colony formation of tumor cells by suppressing β-catenin [45]. Here, IL36RN is linked to renal cell carcinoma.